Nowadays, there are four HDACi approved for curing cancer, which include Vorinostat (SAHA) [42], Romidepsin (FK228) [43], Belinostat (PXD-101) [44], Chidamide [45] (for cutaneous T-cell lymphoma (CTCL) or peripheral T cell lymphoma (PTCL)) and Panbinostat (LBH-589) [46] (for multiple myeloma)
As in the case of studies targeting the caudate nucleus, it remains unclear whether these discrepancies reflect the small size of the studies, their technical limitations, or true clinical differences between subpopulations of OCD patients
[2] Cell Line:PDL9 cells Concentration:25 M Incubation Time:5 days Result:Decreased the protein levels of representative senescent markers, including p16, p21, and p53
This might mean starting at 1mg or 1.5mg rather than the standard 2.5mg